Literature DB >> 11818470

Heart transplantation: a thirty-year perspective.

Douglas N Miniati1, Robert C Robbins.   

Abstract

Heart transplantation has evolved over the past 30 years into a mainstay of therapy for heart failure patients. As the surgical technique and basic immunology were defined, heart transplantation became a real therapeutic option. Over the next few decades, thoracic transplant teams at Stanford University and other institutions refined this mode of therapy. This review addresses the history, current surgical technique, recipient and donor selection, postoperative care, immunosuppression, short- and long-term complications, and clinical outcomes associated with this procedure.

Entities:  

Mesh:

Year:  2002        PMID: 11818470     DOI: 10.1146/annurev.med.53.082901.104050

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  18 in total

1.  Adipose tissue-derived stem cells display a proangiogenic phenotype on 3D scaffolds.

Authors:  Evgenios A Neofytou; Edwin Chang; Bhagat Patlola; Lydia-Marie Joubert; Jayakumar Rajadas; Sanjiv S Gambhir; Zhen Cheng; Robert C Robbins; Ramin E Beygui
Journal:  J Biomed Mater Res A       Date:  2011-05-31       Impact factor: 4.396

Review 2.  [Perioperative implications of heart transplant].

Authors:  H K Eltzschig; B Zwissler; T W Felbinger
Journal:  Anaesthesist       Date:  2003-08       Impact factor: 1.041

Review 3.  Getting to the heart of tissue engineering.

Authors:  Luda Khait; Louise Hecker; Nicole R Blan; Garrett Coyan; Francesco Migneco; Yen-Chih Huang; Ravi K Birla
Journal:  J Cardiovasc Transl Res       Date:  2008-01-29       Impact factor: 4.132

4.  Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification.

Authors:  Lauren D Black; Jason D Meyers; Justin S Weinbaum; Yevgeniya A Shvelidze; Robert T Tranquillo
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

5.  Circulating donor-derived cell-free DNA: a true biomarker for cardiac allograft rejection?

Authors:  Kevin P Daly
Journal:  Ann Transl Med       Date:  2015-03

6.  End-stage Heart Failure: Surgical Therapy and Implantable Devices.

Authors:  Mohamad El-Zaru; David DeNofrio
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-12

7.  Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice.

Authors:  Filip K Swirski; Moritz Wildgruber; Takuya Ueno; Jose-Luiz Figueiredo; Peter Panizzi; Yoshiko Iwamoto; Elizabeth Zhang; James R Stone; Elisenda Rodriguez; John W Chen; Mikael J Pittet; Ralph Weissleder; Matthias Nahrendorf
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

Review 8.  Cardiac allograft vasculopathy: a review.

Authors:  Danny Ramzy; Vivek Rao; Julie Brahm; Santiago Miriuka; Diego Delgado; Heather J Ross
Journal:  Can J Surg       Date:  2005-08       Impact factor: 2.089

9.  Erythroblast transformation-specific 2 correlates with vascular smooth muscle cell apoptosis in rat heterotopic heart transplantation model.

Authors:  Xiaojuan Liu; Daliang Yan; Yangcheng Li; Xilin Sha; Kunpeng Wu; Jianhua Zhao; Chen Yang; Chao Zhang; Jiahai Shi; Xiang Wu
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

10.  Nanoparticle PET-CT detects rejection and immunomodulation in cardiac allografts.

Authors:  Takuya Ueno; Partha Dutta; Edmund Keliher; Florian Leuschner; Maulik Majmudar; Brett Marinelli; Yoshiko Iwamoto; Jose-Luiz Figueiredo; Thomas Christen; Filip K Swirski; Peter Libby; Ralph Weissleder; Matthias Nahrendorf
Journal:  Circ Cardiovasc Imaging       Date:  2013-06-14       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.